Home › Idiopathic Pulmonary Fibrosis › Ohio › Cincinnati
Idiopathic Pulmonary Fibrosis clinical trials in Cincinnati, OH
3 studies for Idiopathic Pulmonary Fibrosis are looking for participants at sites in and around Cincinnati (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
RecruitingPhase 2
- Research Site, Cincinnati
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
RecruitingPhase 2
- University of Cincinnati Medical Center, Cincinnati
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
RecruitingPhase 2
- University of Cincinnati, Cincinnati
Idiopathic Pulmonary Fibrosis trials in other cities
- Birmingham, AL9 studies
- New York City, NY8 studies
- Kansas City, KS7 studies
- Philadelphia, PA7 studies
- Los Angeles, CA7 studies
- Chicago, IL6 studies
- Durham, NC6 studies
- Aurora, CO6 studies
- Dallas, TX5 studies
- Nashville, TN5 studies
- Atlanta, GA5 studies
- Charleston, SC5 studies
Other studies in Cincinnati
- Non-Small Cell Lung Cancer35 studies
- Cancer (all types)28 studies
- Breast Cancer25 studies
- Heart Failure24 studies
- Colorectal Cancer21 studies
- Obesity20 studies
- Metastatic Cancer20 studies
- Acute Myeloid Leukemia20 studies
- Lung Cancer19 studies
- Ovarian Cancer19 studies
- Prostate Cancer18 studies
- Melanoma17 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.